We seek to understand the mechanism(s) by which viruses alter the transcription of Class I genes and thereby impact on the capacity of the host to immunologically regulate the development of leukemia. Two sets of studies will deal with the mechanism(s) by which exogenous viruses such as Radiation leukemia virus (RadLV) deregulate Class I gene expression on infection and transformation of cells. A second set of studies described deal with endogenous viral sequences found inserted in the MHC of normal mice. The prototype virus for these studies is TLev-1, a complete retrovirus located in the TL region of the MHC. For the experimental plan, the proposal will deal with exogenous viruses which deregulate Class I gene expression. For exogenous viruses we wish to: (1) Determine the viral genetic information responsible for deregulation of Class I expression. (2) Identify the trans-acting factors mediating the RadLV effects on H-2 expression. (3) Identify and characterize the cis acting regulatory sequences in the H-2 region with which trans-acting factors interact. (4) Establish differences in cis regulatory sequences between the Dd gene which can be upregulated by RadLV infection) and the Dq (which cannot be upregulated by RadLV). (5) Determine why viral infection is associated with upregulation of murine class I expression, but viral-mediated transformation is associated with downregulation of class I gene of expression. (6) Understand alterations in DNA associated with RadLV transformation such as rearrangements and methylation changes. (7) Establish the frequency with which RadLV integrates in the MHC as compared to other sites.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
5R37CA022247-16
Application #
3481918
Study Section
Allergy and Immunology Study Section (ALY)
Project Start
1977-08-01
Project End
1994-03-31
Budget Start
1993-04-01
Budget End
1994-03-31
Support Year
16
Fiscal Year
1993
Total Cost
Indirect Cost
Name
New York University
Department
Type
Schools of Medicine
DUNS #
004514360
City
New York
State
NY
Country
United States
Zip Code
10012
Tseng, Jen-Chieh; Zanzonico, Pat B; Levin, Brandi et al. (2006) Tumor-specific in vivo transfection with HSV-1 thymidine kinase gene using a Sindbis viral vector as a basis for prodrug ganciclovir activation and PET. J Nucl Med 47:1136-43
Hurtado, Alicia; Tseng, Jen-Chieh; Meruelo, Daniel (2006) Gene therapy that safely targets and kills tumor cells throughout the body. Rejuvenation Res 9:36-44
Hurtado, Alicia; Tseng, Jen-Chieh; Boivin, Christopher et al. (2005) Identification of amino acids of Sindbis virus E2 protein involved in targeting tumor metastases in vivo. Mol Ther 12:813-23
Tseng, Jen-Chieh; Hurtado, Alicia; Yee, Herman et al. (2004) Using sindbis viral vectors for specific detection and suppression of advanced ovarian cancer in animal models. Cancer Res 64:6684-92
Tseng, Jen-Chieh; Levin, Brandi; Hurtado, Alicia et al. (2004) Systemic tumor targeting and killing by Sindbis viral vectors. Nat Biotechnol 22:70-7
Tseng, Jen-Chieh; Levin, Brandi; Hirano, Tadamichi et al. (2002) In vivo antitumor activity of Sindbis viral vectors. J Natl Cancer Inst 94:1790-802
Choi, Jung W; Pampeno, Christine; Vukmanovic, Stanislav et al. (2002) Characterization of the transcriptional expression of Notch-1 signaling pathway members, Deltex and HES-1, in developing mouse thymocytes. Dev Comp Immunol 26:575-88
Pampeno, C L; Vallerie, A M; Choi, J et al. (2001) Genomic analysis and localization of murine Deltex, a modulator of notch activity, to mouse chromosome 5 and its human homolog to chromosome 12. DNA Cell Biol 20:141-8
Ishizu, A; Sawai, K; Ikeda, H et al. (2000) Transduction of a murine dominant negative activation transcription factor 1 increases cell surface expression of the class I MHC on a human epidermoid tumor cell line. Int Immunol 12:161-8
Yu, A; Choi, J; Ohno, K et al. (2000) Specific cell targeting for delivery of toxins into small-cell lung cancer using a streptavidin fusion protein complex. DNA Cell Biol 19:383-8

Showing the most recent 10 out of 43 publications